Inactivation of antithrombin III in synovial fluid from patients with rheumatoid arthritis
Authors:
- R BaileyRBR Bailey
- Z ZhangZZZ Zhang
- K A DunneKDK A Dunne
- D R BlakeDBD R Blake
- N L CoxNCN L Cox
- C J MorrisCMC J Morris
- P G WinyardP G Winyard
- 1 March 1998
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 57 (3) , 162-165
Abstract
To investigate the thrombin inhibitory capacity of antithrombin III in the inflamed human joint. Thrombin inhibitory capacity was measured, using a kinetic spectophotometric method, in matched plasma and synovial fluid samples of patients with rheumatoid arthritis (n = 22) and osteoarthritis (n = 16), together with normal control plasma samples (n = 13). In the same samples, the concentration of antithrombin III was also determined by the method of radial immunodiffusion. The combination of these measurements allowed the calculation of the specific thrombin inhibitory capacity of these samples. An increased concentration of antithrombin III in rheumatoid compared with osteoarthritic synovial fluid was noted (p < 0.05). However, there was a significant depression in the specific activity of antithrombin III in rheumatoid synovial fluid when compared with matched plasma samples (p < 0.001) or with osteoarthritic synovial fluid (p < 0.05). In rheumatoid synovial fluid the thrombin inhibitory capacity of antithrombin III is disproportionately depressed relative to the concentration of antithrombin III, indicating the inactivation of antithrombin III in the rheumatoid joint.Keywords
This publication has 12 references indexed in Scilit:
- Thrombin receptor expression in rheumatoid and osteoarthritic synovial tissue.Annals of the Rheumatic Diseases, 1996
- Coagulant proteins and thrombin generation in synovial fluid: A model for extravascular coagulationAmerican Journal of Hematology, 1995
- INCREASE OF ACTIVATED FACTOR VIIA AND HAEMOSTATIC MOLECULAR MARKERS IN JUVENILE CHRONIC ARTHRITISRheumatology, 1995
- Thrombin in inflammation and healing: relevance to rheumatoid arthritis.Annals of the Rheumatic Diseases, 1994
- Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.Proceedings of the National Academy of Sciences, 1989
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Plakalbumin, α1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosisNature, 1985
- Perturbation of Protease Inhibitors and Substrates in Inflammatory ArthritisSeminars in Thrombosis and Hemostasis, 1985
- Inhibition of antithrombin III by lipid peroxidesThrombosis Research, 1985
- Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH)Thrombosis Research, 1977